These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7898868)

  • 1. Subretinal hemorrhage removal with multiple retinotomy sites in age-related macular degeneration.
    Millsap CM; Peyman GA; Greve MD
    Ophthalmic Surg; 1994; 25(10):723-5. PubMed ID: 7898868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.
    Oshima Y; Ohji M; Tano Y
    Br J Ophthalmol; 2007 Feb; 91(2):193-8. PubMed ID: 16916872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR; Madonna RJ
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration.
    Hesse L; Meitinger D; Schmidt J
    Ger J Ophthalmol; 1996 Nov; 5(6):479-83. PubMed ID: 9479539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT; Sjaarda RN
    Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Krepler K; Kruger A; Tittl M; Stur M; Wedrich A
    Retina; 2000; 20(3):251-6. PubMed ID: 10872929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tissue plasminogen activator (t-PA) in subretinal hemorrhage removal.
    Claes C; Zivojnovic R
    Bull Soc Belge Ophtalmol; 1996; 261():115-8. PubMed ID: 9009370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration.
    Fine HF; Iranmanesh R; Del Priore LV; Barile GR; Chang LK; Chang S; Schiff WM
    Retina; 2010; 30(10):1588-94. PubMed ID: 20856172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.
    Singh RP; Patel C; Sears JE
    Br J Ophthalmol; 2006 Apr; 90(4):429-31. PubMed ID: 16547320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
    Schulze SD; Hesse L
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas.
    Hesse L; Kroll P
    Adv Ther; 1997; 14(5):275-80. PubMed ID: 10174620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subretinal hemorrhage removal.
    Claes C; Zivojnovic R
    Bull Soc Belge Ophtalmol; 1993; 250():85-8. PubMed ID: 7952366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of submacular hemorrhage combined with tissue plasminogen activator (a case report)].
    Korda V; Dúbravská Z; Hejcmanová D; Rozsíval P
    Cesk Slov Oftalmol; 2006 Jul; 62(4):275-9. PubMed ID: 16895061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.
    Peyman GA; Nelson NC; Alturki W; Blinder KJ; Paris CL; Desai UR; Harper CA
    Ophthalmic Surg; 1991 Oct; 22(10):575-82. PubMed ID: 1961614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy.
    Vander JF
    Ophthalmic Surg; 1992 May; 23(5):361-3. PubMed ID: 1603542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration.
    Merrill PT; LoRusso FJ; Lomeo MD; Saxe SJ; Khan MM; Lambert HM
    Ophthalmology; 1999 Apr; 106(4):782-9. PubMed ID: 10201603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
    Dewilde E; Delaere L; Vaninbroukx I; Van Calster J; Stalmans P
    Acta Ophthalmol; 2014 Sep; 92(6):e497-8. PubMed ID: 24943231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitreous surgery for subretinal neovascular membrane and hemorrhage].
    Lü L; Gao R; Wu L
    Zhonghua Yan Ke Za Zhi; 1996 Jul; 32(4):277-81. PubMed ID: 9590844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of fibrinolytic agents during surgical treatment for submacular hemorrhages of various etiology].
    Sosnovskiĭ VV; Sdobnikova SV
    Vestn Oftalmol; 2008; 124(6):47-51. PubMed ID: 19205404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.